Abstract

Promotion of good mental health, prevention, and early intervention before/at the onset of mental disorders improve outcomes. However, the range and peak ages at onset for mental disorders are not fully established. To provide robust, global epidemiological estimates of age at onset for mental disorders, we conducted a PRISMA/MOOSE-compliant systematic review with meta-analysis of birth cohort/cross-sectional/cohort studies, representative of the general population, reporting age at onset for any ICD/DSM-mental disorders, identified in PubMed/Web of Science (up to 16/05/2020) (PROSPERO:CRD42019143015). Co-primary outcomes were the proportion of individuals with onset of mental disorders before age 14, 18, 25, and peak age at onset, for any mental disorder and across International Classification of Diseases 11 diagnostic blocks. Median age at onset of specific disorders was additionally investigated. Across 192 studies (n = 708,561) included, the proportion of individuals with onset of any mental disorders before the ages of 14, 18, 25 were 34.6%, 48.4%, 62.5%, and peak age was 14.5 years (k = 14, median = 18, interquartile range (IQR) = 11–34). For diagnostic blocks, the proportion of individuals with onset of disorder before the age of 14, 18, 25 and peak age were as follows: neurodevelopmental disorders: 61.5%, 83.2%, 95.8%, 5.5 years (k = 21, median=12, IQR = 7–16), anxiety/fear-related disorders: 38.1%, 51.8%, 73.3%, 5.5 years (k = 73, median = 17, IQR = 9–25), obsessive-compulsive/related disorders: 24.6%, 45.1%, 64.0%, 14.5 years (k = 20, median = 19, IQR = 14–29), feeding/eating disorders/problems: 15.8%, 48.1%, 82.4%, 15.5 years (k = 11, median = 18, IQR = 15–23), conditions specifically associated with stress disorders: 16.9%, 27.6%, 43.1%, 15.5 years (k = 16, median = 30, IQR = 17–48), substance use disorders/addictive behaviours: 2.9%, 15.2%, 48.8%, 19.5 years (k = 58, median = 25, IQR = 20–41), schizophrenia-spectrum disorders/primary psychotic states: 3%, 12.3%, 47.8%, 20.5 years (k = 36, median = 25, IQR = 20–34), personality disorders/related traits: 1.9%, 9.6%, 47.7%, 20.5 years (k = 6, median = 25, IQR = 20–33), and mood disorders: 2.5%, 11.5%, 34.5%, 20.5 years (k = 79, median = 31, IQR = 21–46). No significant difference emerged by sex, or definition of age of onset. Median age at onset for specific mental disorders mapped on a time continuum, from phobias/separation anxiety/autism spectrum disorder/attention deficit hyperactivity disorder/social anxiety (8-13 years) to anorexia nervosa/bulimia nervosa/obsessive-compulsive/binge eating/cannabis use disorders (17-22 years), followed by schizophrenia, personality, panic and alcohol use disorders (25-27 years), and finally post-traumatic/depressive/generalized anxiety/bipolar/acute and transient psychotic disorders (30-35 years), with overlap among groups and no significant clustering. These results inform the timing of good mental health promotion/preventive/early intervention, updating the current mental health system structured around a child/adult service schism at age 18.

Details

Title
Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies
Author
Solmi, Marco 1   VIAFID ORCID Logo  ; Radua Joaquim 2 ; Olivola Miriam 3 ; Croce Enrico 4 ; Soardo Livia 5   VIAFID ORCID Logo  ; Salazar de Pablo Gonzalo 6 ; Il Shin Jae 7 ; Kirkbride, James B 8   VIAFID ORCID Logo  ; Jones, Peter 9   VIAFID ORCID Logo  ; Han, Kim Jae 10 ; Kim Jong Yeob 10 ; Carvalho, Andrè F 11 ; Seeman, Mary V 12   VIAFID ORCID Logo  ; Correll, Christoph U 13 ; Fusar-Poli, Paolo 14   VIAFID ORCID Logo 

 University of Padua, Neurosciences Department, Padua, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470); University of Padua, Neuroscience Centre, Padua, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470); Institute of Psychiatry, Psychology & Neuroscience, King’s College London, Department of Psychosis Studies, Early Psychosis: Interventions and Clinical-detection (EPIC) Lab, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764) 
 Institute of Psychiatry, Psychology & Neuroscience, King’s College London, Department of Psychosis Studies, Early Psychosis: Interventions and Clinical-detection (EPIC) Lab, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764); Imaging Mood- and Anxiety-Related Disorders (IMARD) group, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Mental Health Research Networking Center (CIBERSAM), Barcelona, Spain (GRID:grid.10403.36) (ISNI:0000000091771775); Karolinska Institutet, Department of Clinical Neuroscience, Centre for Psychiatric Research and Education, Solna, Sweden (GRID:grid.465198.7) 
 Institute of Psychiatry, Psychology & Neuroscience, King’s College London, Department of Psychosis Studies, Early Psychosis: Interventions and Clinical-detection (EPIC) Lab, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764) 
 University of Ferrara, Department of Biomedical and Specialty Surgical Sciences, Institute of Psychiatry, Ferrara, Italy (GRID:grid.8484.0) (ISNI:0000 0004 1757 2064) 
 University of Pavia, Department of Brain and Behavioral Sciences, Pavia, Italy (GRID:grid.8982.b) (ISNI:0000 0004 1762 5736) 
 Institute of Psychiatry, Psychology & Neuroscience, King’s College London, Department of Psychosis Studies, Early Psychosis: Interventions and Clinical-detection (EPIC) Lab, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764); King’s College London, Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764); Hospital General Universitario Gregorio Marañón School of Medicine, Universidad Complutense, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), CIBERSAM, Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Madrid, Spain (GRID:grid.4795.f) (ISNI:0000 0001 2157 7667) 
 Yonsei University College of Medicine, Department of Pediatrics, Seoul, South Korea (GRID:grid.15444.30) (ISNI:0000 0004 0470 5454) 
 University College London, Division of Psychiatry, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201) 
 University of Cambridge, Department of Psychiatry, Cambridge, England (GRID:grid.5335.0) (ISNI:0000000121885934); Cambridgeshire and Peterborough National Health Service Foundation Trust, CAMEO Early Intervention Service, Cambridge, England (GRID:grid.5335.0) 
10  Yonsei University College of Medicine, Seoul, South Korea (GRID:grid.15444.30) (ISNI:0000 0004 0470 5454) 
11  School of Medicine, Barwon Health, Deakin University, IMPACT (Innovation in Mental and Physical Health and Clinical Treatment) Strategic Research Centre, Geelong, VIC, Australia (GRID:grid.414257.1) (ISNI:0000 0004 0540 0062) 
12  Department of Psychiatry, University of Toronto, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938) 
13  Zucker Hillside Hospital, Department of Psychiatry, Glen Oaks, USA (GRID:grid.440243.5) (ISNI:0000 0004 0453 5950); Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Department of Psychiatry and Molecular Medicine, Hempstead, USA (GRID:grid.512756.2) (ISNI:0000 0004 0370 4759); Feinstein Institute for Medical Research, Center for Psychiatric Neuroscience, Manhasset, USA (GRID:grid.250903.d) (ISNI:0000 0000 9566 0634); Charité-Universitätsmedizin Berlin, Department of Child and Adolescent Psychiatry, Berlin, Germany (GRID:grid.6363.0) (ISNI:0000 0001 2218 4662) 
14  Institute of Psychiatry, Psychology & Neuroscience, King’s College London, Department of Psychosis Studies, Early Psychosis: Interventions and Clinical-detection (EPIC) Lab, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764); University of Pavia, Department of Brain and Behavioral Sciences, Pavia, Italy (GRID:grid.8982.b) (ISNI:0000 0004 1762 5736); OASIS service, South London and Maudsley NHS Foundation Trust, London, UK (GRID:grid.37640.36) (ISNI:0000 0000 9439 0839); Maudsley Biomedical Research Centre, National Institute for Health Research, London, UK (GRID:grid.451056.3) (ISNI:0000 0001 2116 3923) 
Pages
281-295
Publication year
2022
Publication date
Jan 2022
Publisher
Nature Publishing Group
ISSN
13594184
e-ISSN
14765578
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2644217434
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.